-
Mashup Score: 0Nasal host response-based screening for undiagnosed respiratory viruses: a pathogen surveillance and detection study - 1 year(s) ago
These results confirm CXCL10 as a robust nasopharyngeal biomarker of viral respiratory infection and support host response-based screening followed by metagenomic sequencing of CXCL10-high samples as a practical approach to incorporate clinical samples into pathogen discovery and surveillance efforts.
Source: The Lancet MicrobeCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 2Nasal host response-based screening for undiagnosed respiratory viruses: a pathogen surveillance and detection study - 1 year(s) ago
These results confirm CXCL10 as a robust nasopharyngeal biomarker of viral respiratory infection and support host response-based screening followed by metagenomic sequencing of CXCL10-high samples as a practical approach to incorporate clinical samples into pathogen discovery and surveillance efforts.
Source: The Lancet MicrobeCategories: Infectious Disease, Latest HeadlinesTweet-
We would all want to see broad routine diagnostics in every hospital, but in reality that is rare. Yet, clinics are at the frontline of "discovery". Here an interesting approach for selection of samples for deeper follow up by virus discovery https://t.co/cj2K31MauT
-
-
Mashup Score: 0Strep A treatment, working for now - 1 year(s) ago
Group A Streptococcus infections (strep A) are common and often mild, typically presenting as tonsillitis, pharyngitis, or impetigo. But recent data from the UK show an unusually high incidence of severe strep A with increased reports of scarlet fever cases and progression to invasive group A streptococcal disease (iGAS). As The Lancet Microbe goes to press, the UK Health Security Agency (UKHSA)…
Source: The Lancet MicrobeCategories: Hem/Oncs, Latest HeadlinesTweet-
Strep A treatment, working for now https://t.co/BRFmHn2mN6 via @LancetMicrobe
-
-
Mashup Score: 10Pasteurisation: Pasteur's greatest contribution to health - 1 year(s) ago
December, 2022, marks the 200th year of Louis Pasteur’s birth in Dole, France. Among Pasteur’s major contributions and their benefit to society, the most important is the heat treatment of foods and beverages to reduce spoilage and eliminate pathogens for consumers. This process became known as pasteurisation while Pasteur was still alive.1
Source: The Lancet MicrobeCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
RT @LancetMicrobe: New comment> Pasteurisation: Pasteur's greatest contribution to health https://t.co/Jd5K4eLNrM
-
-
Mashup Score: 79Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccines - 1 year(s) ago
The SARS-CoV-2 omicron variant XBB sublineage, a BA.2.10.1–BA.2.75 recombinant classified as variant under monitoring by WHO, has been found in 35 countries,1 and has become the dominant strain in Singapore. There is early evidence suggesting that XBB might be associated with a higher risk of reinfection.2 A previous study using a pseudovirus neutralisation test and sera from individuals who…
Source: The Lancet MicrobeCategories: General Medicine News, Latest HeadlinesTweet-
RT @EricTopol: More data confirming the marked immune evasion of the XBB variants https://t.co/kysvaDvpaJ @LancetMicrobe https://t.co/MG1M9…
-
-
Mashup Score: 15Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccines - 1 year(s) ago
The SARS-CoV-2 omicron variant XBB sublineage, a BA.2.10.1–BA.2.75 recombinant classified as variant under monitoring by WHO, has been found in 35 countries,1 and has become the dominant strain in Singapore. There is early evidence suggesting that XBB might be associated with a higher risk of reinfection.2 A previous study using a pseudovirus neutralisation test and sera from individuals who…
Source: The Lancet MicrobeCategories: Expert Picks, Latest HeadlinesTweet-
More data confirming the marked immune evasion of the XBB variants https://t.co/kysvaDvpaJ @LancetMicrobe https://t.co/MG1M99ZKKb
-
-
Mashup Score: 18Vaccines need equity to really work - 1 year(s) ago
On Nov 9, 2022, WHO published its Global Vaccine Market Report 2022, which analyses data on global vaccine distribution framed in the context of the COVID-19 pandemic. The document highlights some positive achievements over the past years, notably the development of vaccines against severe diseases mainly affecting low-income and middle-income countries; the strengthening of vaccine distribution…
Source: The Lancet MicrobeCategories: Latest Headlines, PulmonologyTweet-
RT @LancetMicrobe: Our December editorial> Vaccines need equity to really work https://t.co/4rXkcLO8K7
-
-
Mashup Score: 16Vaccines need equity to really work - 1 year(s) ago
On Nov 9, 2022, WHO published its Global Vaccine Market Report 2022, which analyses data on global vaccine distribution framed in the context of the COVID-19 pandemic. The document highlights some positive achievements over the past years, notably the development of vaccines against severe diseases mainly affecting low-income and middle-income countries; the strengthening of vaccine distribution…
Source: The Lancet MicrobeCategories: Infectious Disease, Latest HeadlinesTweet-
RT @LancetMicrobe: Our December editorial> Vaccines need equity to really work https://t.co/4rXkcLO8K7
-
-
Mashup Score: 7Vaccines need equity to really work - 1 year(s) ago
On Nov 9, 2022, WHO published its Global Vaccine Market Report 2022, which analyses data on global vaccine distribution framed in the context of the COVID-19 pandemic. The document highlights some positive achievements over the past years, notably the development of vaccines against severe diseases mainly affecting low-income and middle-income countries; the strengthening of vaccine distribution…
Source: The Lancet MicrobeCategories: Future of Medicine, Latest HeadlinesTweet-
RT @LancetMicrobe: Our December editorial> Vaccines need equity to really work https://t.co/4rXkcLO8K7
-
-
Mashup Score: 2Vaccines need equity to really work - 1 year(s) ago
On Nov 9, 2022, WHO published its Global Vaccine Market Report 2022, which analyses data on global vaccine distribution framed in the context of the COVID-19 pandemic. The document highlights some positive achievements over the past years, notably the development of vaccines against severe diseases mainly affecting low-income and middle-income countries; the strengthening of vaccine distribution…
Source: The Lancet MicrobeCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
RT @LancetMicrobe: Our December editorial> Vaccines need equity to really work https://t.co/4rXkcLO8K7
-
Nasal host response-based #screening for #undiagnosed #respiratory #viruses: a #pathogen #surveillance and detection study https://t.co/sVtBQHDL9e https://t.co/jIvAUAwQtD